See‐Tong Pang

4.0k total citations
174 papers, 2.4k citations indexed

About

See‐Tong Pang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, See‐Tong Pang has authored 174 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 47 papers in Molecular Biology and 38 papers in Surgery. Recurrent topics in See‐Tong Pang's work include Prostate Cancer Treatment and Research (31 papers), Bladder and Urothelial Cancer Treatments (28 papers) and Renal cell carcinoma treatment (23 papers). See‐Tong Pang is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Bladder and Urothelial Cancer Treatments (28 papers) and Renal cell carcinoma treatment (23 papers). See‐Tong Pang collaborates with scholars based in Taiwan, United States and Sweden. See‐Tong Pang's co-authors include Cheng‐Keng Chuang, Tung-Ming Pan, Hung‐Wei Yang, Ying‐Hsu Chang, Åke Pousette, Wen‐Hui Weng, Gunnar Norstedt, Amilcar Flores‐Morales, Mu‐Yi Hua and Jim-Long Her and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

See‐Tong Pang

159 papers receiving 2.4k citations

Peers

See‐Tong Pang

PRM

ONCOL

SURGE

Yueyin Pan China

Xudong Zhu China

Xiaowei Qi China

Rosa Terracciano Italy

Yukihiro Hama Japan

Jeffrey G. Bell United States

Salem Billan Israel

Sung Hee Lim South Korea

Yoshinori Koyama Japan

Peter M. Wilson United States

Yueyin Pan China

See‐Tong Pang

735 ×0.9

620 ×1.1

PRM

747 ×1.7

ONCOL

183 ×0.4

SURGE

641 ×1.9

Citations per year, relative to See‐Tong Pang See‐Tong Pang (= 1×) peers Yueyin Pan

Countries citing papers authored by See‐Tong Pang

Since Specialization

Citations

This map shows the geographic impact of See‐Tong Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by See‐Tong Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites See‐Tong Pang more than expected).

Fields of papers citing papers by See‐Tong Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by See‐Tong Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by See‐Tong Pang. The network helps show where See‐Tong Pang may publish in the future.

Co-authorship network of co-authors of See‐Tong Pang

This figure shows the co-authorship network connecting the top 25 collaborators of See‐Tong Pang. A scholar is included among the top collaborators of See‐Tong Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with See‐Tong Pang. See‐Tong Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Dong‐Yi, Ming‐Jer Hsieh, Tien‐Hsing Chen, et al.. (2025). Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning. Cancers. 17(15). 2414–2414. 1 indexed citations

Pang, See‐Tong, Emelie Berglund, I‐Hung Shao, et al.. (2025). First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer. BJUI Compass. 6(6). e70026–e70026. 1 indexed citations

Chien, Ching‐Hui, Kuan‐Lin Liu, Cheng‐Keng Chuang, et al.. (2025). Effects of an app-assisted self-management intervention for urinary incontinence on self-efficacy and related outcomes in men with prostate cancer: A randomized controlled feasibility trial. European Journal of Oncology Nursing. 76. 102888–102888.

Shao, I‐Hung, Li-Jen Wang, Liang‐Kang Huang, et al.. (2024). Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer. Oncology Letters. 28(4). 485–485. 1 indexed citations

Shao, I‐Hung, Ying‐Hsu Chang, Liang‐Kang Huang, et al.. (2024). Nomogram Analysis for Predicting Response to Androgen‐Receptor‐Axis‐Targeted Therapies in Patients With Metastatic Castration‐Resistant Prostate Cancer. Cancer Medicine. 13(21). e70319–e70319. 1 indexed citations

Pang, See‐Tong, Jasmine Lim, Yichun Zhang, et al.. (2024). Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool. Biosensors. 14(12). 599–599. 1 indexed citations

Lin, Po‐Hung, Kai‐Jie Yu, I‐Hung Shao, et al.. (2024). AP-2α gene deregulation is associated with renal cell carcinoma patient survival. BMC Cancer. 24(1). 966–966.

Pan, Tung-Ming, et al.. (2023). Impact of rapid thermal annealing on structural and sensing properties of Ni–Ti sensitive films for extended-gate field-effect transistor pH sensors. Surfaces and Interfaces. 39. 102993–102993. 1 indexed citations

Pan, Tung-Ming, et al.. (2023). Structural properties and sensing performance of Ni–Ti alloy films for extended-gate field-effect transistor pH sensors. Materials Science in Semiconductor Processing. 164. 107639–107639. 3 indexed citations

10.

Wang, Chih‐Chi, Wen‐Lang Fan, Tingting Liu, et al.. (2023). Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study. Anticancer Research. 43(10). 4709–4722. 1 indexed citations

11.

Shao, I‐Hung, Pei‐Hua Peng, Heng‐Hsiung Wu, et al.. (2023). RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition. Cancer Medicine. 12(8). 9788–9801. 7 indexed citations

12.

Chen, Yù, Hong‐Chiang Chang, William J. Huang, et al.. (2023). Consensus of Experts on the Treatment of Sexual Dysfunction after Surgery for Prostate Cancer in Taiwan. Journal of Clinical Medicine. 12(3). 740–740. 5 indexed citations

13.

Fan, Kang‐Hsing, Kai‐Jie Yu, Lan‐Yan Yang, et al.. (2022). Impact of Three-Month Androgen Deprivation Therapy on [68Ga]Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer—Results from a Pilot Prospective Study. Cancers. 14(5). 1329–1329. 10 indexed citations

14.

Matsubara, Nobuaki, Kazuo Nishimura, Satoru Kawakami, et al.. (2022). Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis. Japanese Journal of Clinical Oncology. 52(5). 441–448. 11 indexed citations

15.

Tsai, Chung‐Ying, Hsiang‐Cheng Chi, Ren‐Chin Wu, et al.. (2021). Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma. Biomedicines. 10(1). 8–8. 3 indexed citations

16.

Cheng, Ting, Yuping Li, See‐Tong Pang, et al.. (2019). Normal lung attenuation distribution and lung volume on computed tomography in a Chinese population. SHILAP Revista de lepidopterología. 3 indexed citations

17.

Yang, Lan‐Yan, Yu‐Chun Lin, See‐Tong Pang, et al.. (2018). Metabolic Volumetric Parameters in ¹¹C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer. Contrast Media & Molecular Imaging. 2018. 1–10. 9 indexed citations

18.

Lin, Huan-Tang, Fu-Chao Liu, Jr‐Rung Lin, See‐Tong Pang, & Huang‐Ping Yu. (2018). Impact of the pretransplant dialysis modality on kidney transplantation outcomes: a nationwide cohort study. BMJ Open. 8(6). e020558–e020558. 17 indexed citations

19.

Pang, See‐Tong, et al.. (2015). Paratesticular metastasis from colorectal adenocarcinoma. SHILAP Revista de lepidopterología. 26(1). 72–74. 2 indexed citations

20.

Yeh, Chun‐Nan, et al.. (2009). Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.. PubMed. 21(1). 49–56. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact